M E Hodson

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi Dornase alfa in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis
    M E Hodson
    Cystic Fibrosis Department, Royal Brompton National Heart and Lung Hospital, London, UK
    Pediatr Pulmonol 36:427-32. 2003
  2. ncbi A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
    M E Hodson
    Royal Brompton and Harefield NHS Trust, London, UK
    Eur Respir J 20:658-64. 2002
  3. ncbi New clinical evidence from the European tobramycin trial in cystic fibrosis
    M E Hodson
    Department of Cystic Fibrosis, The Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK
    J Cyst Fibros 1:199-202. 2002
  4. ncbi Treatment of cystic fibrosis in the adult
    M E Hodson
    Department of Cystic Fibrosis, Royal Brompton and Harefield NHS Trust, London, UK
    Respiration 67:595-607. 2000
  5. ncbi Cystic fibrosis and survival to 40 years: a case-control study
    N J Simmonds
    Dept of Cystic Fibrosis, Royal Brompton Hospital, Sydney Street, London, UK
    Eur Respir J 36:1277-83. 2010
  6. ncbi Beyond postural drainage and percussion: Airway clearance in people with cystic fibrosis
    J A Pryor
    Department of Cystic Fibrosis, Royal Brompton and Harefield NHS Foundation Trust, London SW3 6NP, UK
    J Cyst Fibros 9:187-92. 2010
  7. ncbi Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007
    P M George
    Department of Cystic Fibrosis, Royal Brompton Hospital, London SW3 6NP, UK
    BMJ 342:d1008. 2011
  8. ncbi Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function
    N J Simmonds
    Dept of Cystic Fibrosis, Royal Brompton Hospital, London, SW3 6NP, UK
    Eur Respir J 37:1076-82. 2011
  9. ncbi Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis
    S L Elkin
    Department of Cystic Fibrosis at the Royal Brompton Hospital, Imperial College School of Medicine, Sydney Street, London SW3 6NP, UK
    Clin Sci (Lond) 99:309-14. 2000
  10. ncbi A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period
    P L Shah
    Department of Cystic Fibrosis, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, UK
    Respiration 68:160-4. 2001

Collaborators

Detail Information

Publications19

  1. ncbi Dornase alfa in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis
    M E Hodson
    Cystic Fibrosis Department, Royal Brompton National Heart and Lung Hospital, London, UK
    Pediatr Pulmonol 36:427-32. 2003
    ..The analysis suggested that younger patients were likely to benefit more from treatment. The findings of randomized clinical trials were supported by the data collected in routine clinical practice...
  2. ncbi A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis
    M E Hodson
    Royal Brompton and Harefield NHS Trust, London, UK
    Eur Respir J 20:658-64. 2002
    ..Both treatments reduced the bacterial load...
  3. ncbi New clinical evidence from the European tobramycin trial in cystic fibrosis
    M E Hodson
    Department of Cystic Fibrosis, The Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK
    J Cyst Fibros 1:199-202. 2002
    ..008). The safety profile of both treatments was good. We conclude that patients treated with TNS for 1 month experience improved lung function compared with patients treated with colistin...
  4. ncbi Treatment of cystic fibrosis in the adult
    M E Hodson
    Department of Cystic Fibrosis, Royal Brompton and Harefield NHS Trust, London, UK
    Respiration 67:595-607. 2000
    ..Arranging a balanced and reliable system of care - out-patient, in-patient and home care - is essential to ensure the patient's survival and quality of life is as good as possible...
  5. ncbi Cystic fibrosis and survival to 40 years: a case-control study
    N J Simmonds
    Dept of Cystic Fibrosis, Royal Brompton Hospital, Sydney Street, London, UK
    Eur Respir J 36:1277-83. 2010
    ..Even "early-diagnosis" disease appears to have different phenotypes, possibly independent of CF gene function, that have different survival patterns...
  6. ncbi Beyond postural drainage and percussion: Airway clearance in people with cystic fibrosis
    J A Pryor
    Department of Cystic Fibrosis, Royal Brompton and Harefield NHS Foundation Trust, London SW3 6NP, UK
    J Cyst Fibros 9:187-92. 2010
    ....
  7. ncbi Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007
    P M George
    Department of Cystic Fibrosis, Royal Brompton Hospital, London SW3 6NP, UK
    BMJ 342:d1008. 2011
    ..Design Cohort study...
  8. ncbi Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function
    N J Simmonds
    Dept of Cystic Fibrosis, Royal Brompton Hospital, London, SW3 6NP, UK
    Eur Respir J 37:1076-82. 2011
    ..5 (80.0-113.5) mmol·L?¹; young/mild). ? Amil is associated with FEV? but our findings indicate that long-term survival cannot be explained by residual CFTR function when measurements are taken in later life...
  9. ncbi Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis
    S L Elkin
    Department of Cystic Fibrosis at the Royal Brompton Hospital, Imperial College School of Medicine, Sydney Street, London SW3 6NP, UK
    Clin Sci (Lond) 99:309-14. 2000
    ..BMD is also reduced in CF subjects, and this appears to be related to shorter stature in this group...
  10. ncbi A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period
    P L Shah
    Department of Cystic Fibrosis, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, UK
    Respiration 68:160-4. 2001
    ..034). CONCLUSIONS: The trends suggest that dornase alfa may have some influence on disease progression but in view of the limitations of the current study the need for further long-term studies in larger cohorts of patients is emphasised...
  11. ncbi Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study
    S L Elkin
    Department of Cystic Fibrosis, National Heart and Lung Institute, Royal Brompton Hospital, London
    Osteoporos Int 12:366-72. 2001
    ..Low BMD occurs in patients with more severe disease and significantly relates to FEV1, infective exacerbations and daily energy expended in physical activity...
  12. ncbi The psychosocial and psychiatric side of cystic fibrosis in adolescents and adults
    P E Pfeffer
    Department of Cystic Fibrosis, Royal Brompton and Harefield NHS Trust, Sydney Street, London SW3 6NP, UK
    J Cyst Fibros 2:61-8. 2003
    ..Furthermore, older studies are becoming increasingly inapplicable as treatment and prognosis changes. Therefore, more research is needed in this field...
  13. ncbi Inhaled ceftazidime compared with gentamicin and carbenicillin in older patients with cystic fibrosis infected with Pseudomonas aeruginosa
    R J Stead
    Department of Cystic Fibrosis, Cardiothoracic Institute, London
    Br J Dis Chest 81:272-9. 1987
    ....
  14. ncbi Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction
    B Yung
    Department of Cystic Fibrosis and Chemical Pathology, Royal Brompton and Harefield NHS Trust, UK
    Diabet Med 19:221-6. 2002
    ....
  15. ncbi Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure
    B P Madden
    Dept of Cardiothoracic Medicine, St George's Hospital, London, UK
    Eur Respir J 19:310-3. 2002
    ..For these patients, there is a possibility of prolonging life if they are successfully treated for their acute episode of respiratory failure until transplantation. In this group, treatment is not merely prolonging the process of dying...
  16. ncbi Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis
    B Balint
    Dept of Thoracic Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, UK
    Eur Respir J 17:1201-7. 2001
    ....
  17. ncbi Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial
    E W Alton
    Department of Gene Therapy, Imperial College at National Heart and Lung Institute, London, UK
    Lancet 353:947-54. 1999
    ..We studied the safety and efficacy of this gene transfer to the lungs and nose of patients with cystic fibrosis in a double-blind placebo-controlled trial...
  18. ncbi A cohort study of cystic fibrosis and malignancy
    C D Sheldon
    Department of Cystic Fibrosis, Royal Brompton National Heart and Lung Hospital Chelsea, London, UK
    Br J Cancer 68:1025-8. 1993
    ..0001) during the period to mid 1991. On the basis of the present findings and previous case reports in the literature adenocarcinoma of the pancreas and adenocarcinoma of the terminal ileum may be associated with cystic fibrosis...
  19. ncbi Heart lung transplantation for cystic fibrosis
    M E Hodson
    Department of Cystic Fibrosis, Brompton Hospital, London, United Kingdom
    Acta Univ Carol Med (Praha) 36:207-9. 1990
    ..The physicians caring for CF patients in the UK are extremely grateful to our surgeons, Professor M Yacoub, Harefield and Brompton Hospitals, and Mr John Wallwork, Papworth Hospital, Cambridge for their pioneering work...